We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Proteomics, "Zombie" Cells and Clinical Biomarkers of Aging

Article   Jan 16, 2020 | By Molly Campbell, Science Writer, Technology Networks

 
Proteomics, "Zombie" Cells and Clinical Biomarkers of Aging

Brightfield microscopy images of senescent lung fibroblasts (left) and senescent renal epithelial cells (right). Blue staining of the cells is an indicator of senescence-associated beta-galactosidase activity, a marker present only on senescent cells. Credit: Nathan Basisty, PhD.

 
 
Advertisement
 

RELATED ARTICLES

European Proteomics Infrastructure Consortium – Providing Access

Article

The European Proteomics Infrastructure Consortium providing Access, or EPIC-XS, started in January 2019. It brings together a consortium of world-leading, highly innovative European proteomics facilities with the shared goal of supporting excellent life sciences research in Europe. In this article, Martina O'Flaherty provides an overview of some of the successes of the consortium so far.

READ MORE

Measuring Real-Time Cell Therapy Potency With Bioelectronic Assays

Article

As CAR T cells become more popular, the value of potency monitoring will become clearer. Assays that use bioelectrodes to measure the potency of immune cells offer a new approach in cell therapy development.

READ MORE

Why mRNA Vaccines Could Be a Game Changer

Article

In this article, Amber Schmidtke explores why mRNA vaccines might chart out path to a safer, healthier future.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Cell Science Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE